STEAP1–4 (Six-Transmembrane Epithelial Antigen of the Prostate 1–4) and Their Clinical Implications for Prostate Cancer

SIMPLE SUMMARY: Despite recent therapeutic advances in the treatment of prostate cancer, metastatic castration-resistant prostate cancer continues to cause significant morbidity and mortality. New research into highly expressed proteins in metastatic castration-resistant prostate cancer shows that S...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Michael, Evans, Latese, Bizzaro, Candice L., Quaglia, Fabio, Verrillo, Cecilia E., Li, Li, Stieglmaier, Julia, Schiewer, Matthew J., Languino, Lucia R., Kelly, William K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9406800/
https://www.ncbi.nlm.nih.gov/pubmed/36011027
http://dx.doi.org/10.3390/cancers14164034

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9406800/
https://www.ncbi.nlm.nih.gov/pubmed/36011027
http://dx.doi.org/10.3390/cancers14164034

Ejemplares similares